Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

DURECT Corporation (DRRX)

0.6847   0.023 (3.43%) 07-15 16:00
Open: 0.6772 Pre. Close: 0.662
High: 0.69 Low: 0.67
Volume: 213,111 Market Cap: 111M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.691 - 0.694 0.694 - 0.696
Low: 0.663 - 0.666 0.666 - 0.669
Close: 0.675 - 0.68 0.68 - 0.684

Technical analysis

as of: 2019-07-15 4:41:31 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.89     One year: 1.04
Support: Support1: 0.60    Support2: 0.50
Resistance: Resistance1: 0.76    Resistance2: 0.89
Pivot: 0.66
Moving Average: MA(5): 0.67     MA(20): 0.64
MA(100): 0.66     MA(250): 0.85
MACD: MACD(12,26): 0.02     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 53.29     %D(3): 56.61
RSI: RSI(14): 58.85
52-week: High: 1.66  Low: 0.46  Change(%): -56.4
Average Vol(K): 3-Month: 99302  10-Days: 40801

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
DRRX has closed below upper band by 22.6%. Bollinger Bands are 64.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to DRRX's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 30 Jul 2018 17:10:31 Z
Why Durect Corporation Stock Is Spiking Today

Thu, 28 Jun 2018 21:07:21 Z
Pain, Durect Plunge as FDA Committee Votes Against Remoxy ER

Wed, 27 Jun 2018 20:09:30 Z
Notable Wednesday Option Activity: DRRX, UAA, CLR

Wed, 27 Jun 2018 19:08:52 Z
Here's Why Drug Developer DURECT Corporation Plunged Today

Fri, 20 Oct 2017 20:19:33 Z
Health Care Sector Update for 10/20/2017: CELG,ACRX,DRRX

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 162.36
Shares Float (M) 156.78
% Held by Insiders 3.97
% Held by Institutions 46.07
Shares Short (K) 5000
Shares Short P. Month (K)

Stock Financials

EPS -0.151
EPS Est. Current Year -0.240
EPS Est. Next Year -0.170
EPS Est. Next Quarter -0.050
Forward EPS -0.220
Book Value (p.s.) 0.090
PEG Ratio -0.19
Profit Margin -125.76
Operating Margin -117.13
Return on Assets (ttm) -25.2
Return on Equity (ttm) -107.9
Qtrly Rev. Growth 18.4
Gross Profit (p.s.) -0.069
Sales Per Share
EBITDA (p.s.) -0.137
Qtrly Earnings Growth
Operating Cash Flow (M) -18.72
Levered Free Cash Flow (M) -11.45

Stock Valuations

P/E -4.53
P/E Growth Ratio 0.04
P/BV 7.61
P/S 926399168.00
P/CF -5.94

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.